Vitamin B1 Injection 100mg/mL

Vitamin B1 Injection | Vitamin B Supplement Injection
  • Dosage: Vitamin B1 100mg
  • Volume:  1 ml Ampoule
  • Packaging: 1 ml ampoule * 10/tray/box*300 carton
  • Shelf Life: 36 months 

Click to add this item to cart.

Product Description

Product NameVitamin B1 (Thiamine Hydrochloride) Injection
Specification100mg/1mL (100mg/mL)
Dosage FormSterile Solution for Injection
Active IngredientThiamine Hydrochloride (Vitamin B1)
Pharmacological ClassWater-Soluble B Vitamin / Coenzyme in Carbohydrate Metabolism
Route of AdministrationIntramuscular injection (preferred), or slow intravenous injection / intravenous infusion (after dilution). Rapid intravenous bolus injection is NOT recommended.
Packaging1mL amber glass ampoule
StorageStore below 25°C, protected from light. Do not freeze. Keep ampoule in outer carton until use.
Shelf Life36 months (unopened)

Product Overview

Vitamin B1 (Thiamine Hydrochloride) Injection 100mg/1mL is a sterile, aqueous solution of thiamine hydrochloride intended for parenteral administration. Each 1mL ampoule contains 100mg of thiamine hydrochloride at a concentration of 100mg/mL. Thiamine (vitamin B1) is an essential water-soluble B-complex vitamin that cannot be synthesized by the human body and must be obtained through dietary intake or supplementation. It plays a fundamental role in cellular energy metabolism, particularly in the oxidative decarboxylation of carbohydrates and the maintenance of normal neurological and cardiovascular function. The parenteral formulation is designed for use in situations where oral supplementation is not feasible, such as in patients with gastrointestinal malabsorption, severe vomiting, postoperative states, or when rapid correction of thiamine deficiency is required.

Vitamin B1 Injection 100mg/mL: What the Published Guidance Says

Our largest functional group by product count — from the individual vitamins and minerals carried on the WHO Model List through to parenteral nutrition components and finished multivitamin presentations.

Buyers usually settle three things before ordering Vitamin B1 Injection 100mg/mL: the pharmacopoeial monograph, the pack configuration, and the documents the destination authority will ask for.

  • The economic case for essential medicines is documented WHO reports that medicines account for 20–60% of health spending in developing countries, with up to 90% of the population purchasing medicines through out-of-pocket payments, making medicines the largest family expenditure item after food. The 2025 Model List covers over 520 medicines, including 374 for children. WHO — Essential medicines (fact sheet)
  • The Model List sections that carry this portfolio Vitamins and minerals sit in section 27 of the 24th WHO Model List (2025). The listings include ascorbic acid, cholecalciferol and ergocalciferol, iodine, nicotinamide, pyridoxine and retinol, alongside calcium and other minerals. WHO Model List of Essential Medicines, 24th List (2025) — report of the 25th WHO Expert Committee (TRS 1064)
  • Anaemia prevention is a listed intervention Ferrous salt with folic acid appears on the Model List as an antianaemia medicine, in tablet form. Folic acid and iron are the standard pair used in national supplementation programmes, and matching your market's programme strength matters. WHO — Essential medicines (fact sheet)

Each point above is reproduced because it has a practical consequence for Vitamin B1 Injection 100mg/mL: the strength you can register, the pack you can release, or the wording permitted on the label. Your national prescribing information always takes precedence.

Ordering Parameters for Vitamin B1 Injection 100mg/mL

Product NameVitamin B1 (Thiamine Hydrochloride) Injection
Specification100mg/1mL (100mg/mL)
Dosage FormSterile Solution for Injection
Active IngredientThiamine Hydrochloride (Vitamin B1)
Pharmacological ClassWater-Soluble B Vitamin / Coenzyme in Carbohydrate Metabolism
Route of AdministrationIntramuscular injection (preferred), or slow intravenous injection / intravenous infusion (after dilution). Rapid intravenous bolus injection is NOT recommended.
StorageStore below 25°C, protected from light. Do not freeze. Keep ampoule in outer carton until use.
Therapeutic groupVitamins & Nutrition — Vitamins & Nutrition
ManufacturerSinophare Bio-technology Co., Ltd. (GMP, China)
Documentation suppliedCOA, HPLC/GC data, stability data, dossier package

The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: Alpha-Lipoic Acid Injection 5ml:125mg, L-Carnitine Injection 2ml:500mg, Pyridoxine Injection 1ml:100mg, Glutathione Injection 3000mg, Coenzyme Q10 Injection 2ml:5mg, Biotin Injection 5ml:500μg, Levocarnitine Injection 5ml:1000mg, Iron Sucrose Injection 5ml:100mg Ampoule.

Pharmacopoeial Standard, Release Testing & COA

Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.

Release testing for Vitamin B1 Injection 100mg/mL follows the monograph you nominate — USP, EP, BP or CP. If the presentation is not covered by a monograph, the specification is frozen in writing with your quality team before the batch is manufactured.

Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.

The quality control package for the marketed pack covers:

  • Testing for assay of the active substance
  • Testing for related substances and impurities
  • Testing for dissolution or release profile (solid oral forms)
  • Testing for uniformity of dosage units
  • Testing for water content and pH where applicable
  • Testing for sterility and bacterial endotoxins (parenterals and ophthalmics)

COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.

Packing, Labelling Languages & Export Paperwork

  • Pack size: 1mL amber glass ampoule. Non-standard pack sizes can be quoted against your artwork.
  • Storage: Store below 25°C, protected from light. Do not freeze. Keep ampoule in outer carton until use..
  • Shelf life: 36 months (unopened). Stability data for the marketed pack is included in the dossier.
  • Labelling: we typeset the carton and leaflet in English, Arabic, French, Russian and Spanish and in any further language your market requires, carrying your own brand where the local rules allow.
  • Export: commercial invoice, packing list, certificate of origin, GMP certificate, COA and the free-sale certificate issued by the country of manufacture whenever your customs or regulator asks for it.

Marketing Authorisation & Tender Support

The legal manufacturer named on every document for Vitamin B1 Injection 100mg/mL is Sinophare Bio-technology Co., Ltd., DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. The same entity appears on the GMP certificate and on the dossier submitted to your regulator.

  • Re-test or renewal support when the marketing authorisation comes up for variation or renewal.
  • CTD dossier modules 1–5 in editable and PDF form, with the finished-product and API sections cross-referenced.
  • Site Master File and GMP certificate for the manufacturing workshops.
  • Method validation, stability protocol and the shelf-life justification for the marketed pack.
  • Answers to authority questions during assessment, handled by the regulatory contact who prepared the file.

Vitamin B1 Injection 100mg/mL is presented here against vitamins, minerals and clinical nutrition products named in the WHO Model List. Inclusion in an essential-medicines list does not authorise sale in any particular country — the marketing authorisation for that market is a separate step.

Vitamin B1 Injection 100mg/mL: Common Procurement Questions

What pack size is available for Vitamin B1 Injection 100mg/mL?

Standard commercial packaging for this line is 1mL amber glass ampoule. Alternative pack sizes are produced to your specification and are supported by the corresponding stability data.

What documentation comes with a shipment of Vitamin B1 Injection 100mg/mL?

The documentation set for every shipment includes the certificate of analysis (description, identification, assay, related substances), stability data for the marketed pack, and the site GMP certificate. Shelf life: 36 months.

Does the batch documentation for Vitamin B1 Injection 100mg/mL support a registration filing?

The documentation set for every shipment includes the certificate of analysis (description, identification, assay, related substances), stability data for the marketed pack, and the site GMP certificate. Shelf life: 36 months. The full CTD dossier and the authority assessment file are supplied as part of a registration order; routine shipments carry the COA and stability data only.

Do you supply injectable B-complex and vitamin C?

Yes. B-complex, cyanocobalamin, thiamine, pyridoxine, ascorbic acid and combinations are supplied as injectables with assay data on the batch COA.

Which vitamins and minerals are on the WHO Model List?

Section 27 of the Model List carries minerals and vitamins including ascorbic acid, cholecalciferol and ergocalciferol, iodine, nicotinamide, pyridoxine and retinol. Ferrous salt with folic acid is listed as an antianaemia medicine.

Products Commonly Ordered with Vitamin B1 Injection 100mg/mL

Browse the full Vitamins & Nutrition range; all Injectables; the complete product catalogue.

Request a Quotation for Vitamin B1 Injection 100mg/mL

Tell us the monograph, pack size and quantity required for Vitamin B1 Injection 100mg/mL 100mg, together with the destination market, and the quotation will state lead time and the documents that ship with the batch. Samples for registration can be added to the same order.

Request a quotation

Sources & Regulatory Notes

Reference information only. The published guidance summarised on this page is quoted for professional and regulatory-context purposes and does not constitute medical advice, a prescribing recommendation or a promotion of any product for a particular indication. Prescribing decisions must follow the approved product information and national treatment guidelines in the market of use.

<< return to products